Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Medical Dialogues Bureau17 March 2020 5:18 PM IST
    New Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a...
    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Medical Dialogues Bureau8 Feb 2020 10:15 AM IST
    New Delhi: Pharma firm Lupin on Thursday reported widening of its consolidated net loss to Rs 835 crore for the quarter ended December 2019 on account...
    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Farhat Nasim7 Feb 2020 4:43 PM IST
    New Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Medical Dialogues Bureau1 Feb 2020 9:45 AM IST
    Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
    Syngene International Limited announces Q3 FY20 results

    Syngene International Limited announces Q3 FY20 results

    Medical Dialogues Bureau25 Jan 2020 11:00 AM IST
    Reports 11% revenue growth in Q3 to Rs. 539 Cr
    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Medical Dialogues Bureau20 Nov 2019 9:30 AM IST
    Suven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars...
    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Medical Dialogues Bureau16 Nov 2019 9:15 AM IST
    The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7 per cent from Rs 30 crore in Q2 FY19.Mumbai: Leading diagnostic service provider...
    JB Chemicals Q2 PAT jumps 82 pc at Rs 94 crore

    JB Chemicals Q2 PAT jumps 82 pc at Rs 94 crore

    Medical Dialogues Bureau15 Nov 2019 9:32 AM IST
    Mumbai: JB Chemicals and Pharmaceuticals Ltd on Tuesday reported 82 per cent jump in its profit after tax during the second quarter at Rs 94 crore...
    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Medical Dialogues Bureau14 Nov 2019 9:30 AM IST
    Managing director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Medical Dialogues Bureau13 Nov 2019 9:33 AM IST
    "The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Medical Dialogues Bureau5 Nov 2019 12:55 PM IST
    New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Farhat Nasim5 Nov 2019 9:15 AM IST
    Unichem Labs had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, the company said in a filing to the BSE.New...
    Next

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok